Evidence map›Paper›PMID 11564373›Full record

ReviewCurrent rheumatology reports2001

Pathogenesis of reactive arthritis.

J Sieper

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current rheumatology reports, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Microbes, helminths, and rheumatic diseases.Best practice & research. Clinical rheumatology · 2020
    Review
  6. Review
  7. Article
  8. Serum and synovial fluid vitamin D metabolites and rheumatoid arthritis.The Journal of steroid biochemistry and molecular biology · 2019
    Article
  9. Article
  10. Article
  11. The Case of Reactive Arthritis Secondary toCase reports in rheumatology · 2017
    Article
  12. A case of reactive arthritis due to Clostridium difficile colitis.Journal of community hospital internal medicine perspectives · 2016
    Article
  13. The molecular basis for disease phenotype in chronic Chlamydia-induced arthritis.International journal of clinical rheumatology · 2012
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

J SieperDepartment of Internal Medicine I, Rheumatology, University Hospital Benjamin Franklin, Hindenburgdamm 30, 12200 Berlin, Germany. hjsieper@zedat.fu-berlin.de
Franklin University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is good evidence that bacteria persist in vivo in patients with reactive arthritis (ReA). While Chlamydia seem to hide inside the joint, other areas such as gut mucosa or lymph nodes seem to be more likely places for Salmonella and Yersinia. T-helper (Th) 1 cells secreting cytokines such as IFN gamma and TNF alpha are crucial for an effective elimination of these bacteria. An inhibited Th1-response could be demonstrated in ReA, probably contributing to bacterial persistence. While HLA-B27 is found in only approximately 50% of patients with acute ReA, HLA-B27 seems to be crucial for the development of features typical with chronic spondyloarthropathy, such as sacroiliitis. Among several hypotheses to explain the interaction of bacteria with HLA-B27, the most likely seems to be that until now unknown bacterial or self- antigens were presented by HLA-B27 to CD8(+) T-cells. An important site where the immunopathology takes place seems to be at the insertion of tendons and ligaments at bone. Because antibiotics have failed so far in the treatment of ReA immunomodulatory therapies, based on a better understanding of the pathogenesis, alone or in combination with antibiotics might be an option for the future.

Indexed as

Arthritis, ReactiveBacterial InfectionsChronic DiseaseCytokinesEpitopes, T-LymphocyteFemaleHLA-B27 AntigenHumansMalePrognosisProhibitinsRisk AssessmentRisk FactorsSeverity of Illness IndexCytokinesEpitopes, T-LymphocyteHLA-B27 AntigenPHB2 protein, humanProhibitins

Identifiers

PMID11564373
OpenAlexW1965679960

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.